🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
PLX
$PLX
🔒 US EquitiesProtalix Biotherapeutics Inc
AVG HISTORICAL GAP
-3.92%
MAX GAP RECORD
-18.28%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $PLX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$PLX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 12, 2026 Earnings Release 2026-11-12 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 12, 2026 Earnings Release 2026-08-12 (BEFORE OPEN) |
+2.47%
|
| May 13, 2026 Earnings Release 2026-05-13 (BEFORE OPEN) |
+3.14%
|
| Mar 18, 2026 Earnings Release 2026-03-18 (BEFORE OPEN) |
-18.28%
|
| Nov 13, 2025 Earnings Release 2025-11-13 (BEFORE OPEN) |
-14.02%
|
| Aug 14, 2025 Earnings Release 2025-08-14 (BEFORE OPEN) |
-3.11%
|
| May 09, 2025 Earnings Release 2025-05-09 (BEFORE OPEN) |
-17.30%
|
| Mar 17, 2025 Earnings Release 2025-03-17 (BEFORE OPEN) |
+5.80%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
8.4%
Bullish Gaps (6)
Bearish Gaps (7)
Neutral / Flat (0)
📖 Intelligence Summary
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗